361 related articles for article (PubMed ID: 25542076)
1. Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
Sitte HH; Freissmuth M
Trends Pharmacol Sci; 2015 Jan; 36(1):41-50. PubMed ID: 25542076
[TBL] [Abstract][Full Text] [Related]
2. Using Ca
Steele TWE; Eltit JM
Psychopharmacology (Berl); 2019 Mar; 236(3):973-988. PubMed ID: 30448989
[TBL] [Abstract][Full Text] [Related]
3. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
Simmler LD; Rickli A; Hoener MC; Liechti ME
Neuropharmacology; 2014 Apr; 79():152-60. PubMed ID: 24275046
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
[TBL] [Abstract][Full Text] [Related]
5. Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay.
Zwartsen A; Verboven AHA; van Kleef RGDM; Wijnolts FMJ; Westerink RHS; Hondebrink L
Toxicol In Vitro; 2017 Dec; 45(Pt 1):60-71. PubMed ID: 28506818
[TBL] [Abstract][Full Text] [Related]
6. Psychostimulants and monoamine transporters: upsetting the balance.
Elliott JM; Beveridge TJ
Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
[TBL] [Abstract][Full Text] [Related]
7. New insights into the mechanism of action of amphetamines.
Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
[TBL] [Abstract][Full Text] [Related]
8. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
9. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
10. A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content.
Rosenauer R; Luf A; Holy M; Freissmuth M; Schmid R; Sitte HH
ACS Chem Neurosci; 2013 Jan; 4(1):182-90. PubMed ID: 23336057
[TBL] [Abstract][Full Text] [Related]
11. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of monoamine transporters.
Glatt CE; Reus VI
Pharmacogenomics; 2003 Sep; 4(5):583-96. PubMed ID: 12943466
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Simmler LD; Liechti ME
Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
[TBL] [Abstract][Full Text] [Related]
14. The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.
Kern C; Erdem FA; El-Kasaby A; Sandtner W; Freissmuth M; Sucic S
J Biol Chem; 2017 Mar; 292(9):3603-3613. PubMed ID: 28104804
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of monoamine transporters is a lever required for the action of amphetamines.
Sucic S; Dallinger S; Zdrazil B; Weissensteiner R; Jørgensen TN; Holy M; Kudlacek O; Seidel S; Cha JH; Gether U; Newman AH; Ecker GF; Freissmuth M; Sitte HH
J Biol Chem; 2010 Apr; 285(14):10924-38. PubMed ID: 20118234
[TBL] [Abstract][Full Text] [Related]
16. Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action.
Seidel S; Singer EA; Just H; Farhan H; Scholze P; Kudlacek O; Holy M; Koppatz K; Krivanek P; Freissmuth M; Sitte HH
Mol Pharmacol; 2005 Jan; 67(1):140-51. PubMed ID: 15615700
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
18. Overview of Monoamine Transporters.
Aggarwal S; Mortensen OV
Curr Protoc Pharmacol; 2017 Dec; 79():12.16.1-12.16.17. PubMed ID: 29261228
[TBL] [Abstract][Full Text] [Related]
19. Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.
Luethi D; Hoener MC; Liechti ME
Eur J Pharmacol; 2018 Jan; 819():242-247. PubMed ID: 29225192
[TBL] [Abstract][Full Text] [Related]
20. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
